Novel Antibody Exerts Antitumor Effect through Downregulation of CD147 and Activation of Multiple Stress Signals.

MLA

Fukuchi, Keisuke, et al. “Novel Antibody Exerts Antitumor Effect through Downregulation of CD147 and Activation of Multiple Stress Signals.” Journal of Oncology, vol. 2022, Nov. 2022, p. 3552793. EBSCOhost, https://doi.org/10.1155/2022/3552793.

APA

Fukuchi, K., Nanai, K., Yuita, H., Maru, C., Tsukada, J., Ishigami, M., Nagai, Y., Nakano, Y., Yoshimura, C., Yoneda, K., Amano, M., Nakamura, K., Oda, Y., Nishigohri, H., Yamamoto, S., Ohnishi-Totoki, Y., Inaki, K., Komori, H., Nakano, R., … Agatsuma, T. (2022). Novel Antibody Exerts Antitumor Effect through Downregulation of CD147 and Activation of Multiple Stress Signals. Journal of Oncology, 2022, 3552793. https://doi.org/10.1155/2022/3552793

Chicago

Fukuchi, Keisuke, Kayoko Nanai, Hiroshi Yuita, Chikako Maru, Jun Tsukada, Masato Ishigami, Yoko Nagai, et al. 2022. “Novel Antibody Exerts Antitumor Effect through Downregulation of CD147 and Activation of Multiple Stress Signals.” Journal of Oncology 2022 (November): 3552793. doi:10.1155/2022/3552793.